Butler John P. 4
4 · Akebia Therapeutics, Inc. · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
Akebia (AKBA) CEO John Butler Receives Share Awards
What Happened
John P. Butler — CEO, President and Director of Akebia Therapeutics (AKBA) — received equity awards on January 30, 2026. The Form 4 reports a grant of 743,000 restricted stock units (RSUs) and 1,115,000 derivative awards (stock option-style awards), both reported at $0.00, for a total of 1,858,000 awarded shares. These are compensation/award grants, not open-market purchases or sales.
Key Details
- Transaction date: 2026-01-30. Form 4 filed: 2026-02-03 (filed timely).
- Award amounts and reported price:
- 743,000 restricted stock units (RSUs) — $0.00 reported.
- 1,115,000 derivative awards (options-style) — $0.00 reported.
- Vesting:
- RSUs (F1): vest one‑third on each of the first three anniversaries of the grant, subject to continued service.
- Options-style awards (F3): vest over four years — 25% on first anniversary, remaining 75% in equal quarterly installments, subject to continued service.
- Shares owned after transaction: not explicitly stated in the provided filing. Footnote F2 shows at least 162,928 existing shares held previously (159,928 in a 2019 GRAT + 1,500 + 1,500 from ESPP purchases).
- Footnotes of note:
- F1: RSUs granted under 2023 Stock Incentive Plan with 3-year vesting (1/3 each year).
- F3: Option awards under 2023 Plan with standard 4-year vesting schedule.
- F2: breakdown of previously held shares included in prior holdings.
- Timeliness: Filing appears timely (filed within required business-day window).
Context
These awards are standard executive compensation/retention grants and do not represent a cash purchase or sale. RSUs convert to shares only as they vest; options-style awards require vesting (and typically exercise) before resulting in actual shares. Because vesting schedules apply, these grants do not reflect immediate liquidity or a near-term sale by the insider, though they can lead to future dilution if vested shares are issued or options exercised.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-01-30+743,000→ 3,463,849 total - Award
Stock Option (Right to buy)
[F3]2026-01-30+1,115,000→ 1,115,000 totalExercise: $1.41Exp: 2036-01-30→ Common Stock (1,115,000 underlying)
- 159,928(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]Includes 159,928 shares previously held by John Butler 2019 GRAT, and 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
- [F3]The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.